Skip to main content
Irene Rupp Hodge, MD, Infectious Disease, Dover, NH, Wentworth-Douglass Hospital

IrenePattersonRupp HodgeMD

Infectious Disease • Dover, NH

Medical Director Wentworth-Douglass Hospital Wound Healing Institute

Join to view full profile

Dr. Rupp Hodge is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Rupp Hodge's full profile

Already have an account?

Summary

  • I am certified by ABIM in Internal Medicine and Infectious Diseases and by ABWM as a Certified Wound Specialist Physician.

    I am currently practicing wound care and I am the Medical Director of the Wentworth-Douglass Hospital Wound Healing Institute. I also continue to round on the in-patient ID service at Wentworth-Douglass Hospital as well as conduct Antimicrobial Stewardship rounds.

Education & Training

  • Dartmouth-Hitchcock/Mary Hitchcock Memorial Hospital
    Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalFellowship, Infectious Disease, 1994 - 1997
  • Dartmouth-Hitchcock/Mary Hitchcock Memorial Hospital
    Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalResidency, Internal Medicine, 1991 - 1994
  • University of Rochester School of Medicine and Dentistry
    University of Rochester School of Medicine and DentistryClass of 1991

Certifications & Licensure

  • NH State Medical License
    NH State Medical License 1996 - 2024
  • ME State Medical License
    ME State Medical License Active through 2005
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

  • Top Infectious Disease Specialist 2020 New Hampshire Magazine Top Doctors, 2020

Committees

  • Member, Antimicrobial Stewardship Committee 2022 - Present
  • Physician Leader, Antibiotic Stewardship Committee 2011 - 2022
  • Member, Pharmacy, Therapeutics and Nutrition 1999 - 2022
  • Chairman, Infection Prevention 1999 - 2022

Research History

  • Primary InvestigatorEarly Access of MK-0518 in Combination with an Optimized Background Antiretroviral Therapy (OBT) in Highly Treatment Experienced HIV–1 Infected Patient's with Limited or no Treatment Options, Merck & Co., Inc2007 - 2008
  • Principle InvestigatorEarly Access of TMC125 in Combination with Other Antiretrovirals in Treatment–Experienced HIV–1 Infected Subjects with Limited Treatment Options, Tibotec Pharmaceutical, LTP2007 - 2008

Professional Memberships

Hospital Affiliations

Dr. Irene Rupp Hodge, Dr. Irene Rupp Hodge, MD, Dr. I Rupp Hodge, Dr. Irene Patterson Rupp Hodge